Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) shares, rose in value, with the stock price down by -1.30% to the previous day’s close as strong demand from buyers drove the stock to $8.77.
Actively observing the price movement in the recent trading, the stock is buoying the session at $8.88, falling within a range of $8.71 and $8.85. The value of beta (5-year monthly) is 1.103. Referring to stock’s 52-week performance, its high was $11.31, and the low was $6.01. On the whole, BCRX has fluctuated by -20.39% over the past month.
With the market capitalization of Biocryst Pharmaceuticals Inc currently standing at about $1.83 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-05.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 608.13M, with a low estimate of 143.07M and a high estimate of 150M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 148.02M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BCRX’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of BCRX currently trading nearly -7.67% and -12.48% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 32.27, while the 7-day volatility ratio is showing 2.70% which for the 30-day chart, stands at 3.40%. Furthermore, Biocryst Pharmaceuticals Inc (BCRX)’s beta value is 1.11.
A comparison of Biocryst Pharmaceuticals Inc (BCRX) with its peers suggests the former has fared considerably weaker in the market. BCRX showed an intraday change of -1.30% in today’s session so far, and over the past year, it grew by 16.56%%.
Data on historical trading for Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) indicates that the trading volumes over the past 10 days have averaged 3.59 and over the past 3 months, they’ve averaged 4.66 million. According to company’s latest data on outstanding shares, there are 209.21 million shares outstanding.
Nearly 4.24% of Biocryst Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 84.36% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 23.08 million shares as on 2025-06-13, resulting in a short ratio of 5.52. According to the data, the short interest in Biocryst Pharmaceuticals Inc (BCRX) stood at 1107.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 20.98 million. The stock has risen by 35.26% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BCRX stock heading into the next quarter.
